Regulation of mitochondrial proliferation by PGC-1α induces cellular apoptosis in musculoskeletal malignancies

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Onishi, Yasuo ^a   Ueha, Takeshi ^b   Kawamoto, Teruya ^a   Hara, Hitomi ^a   Toda, Mitsunori ^a   Harada, Risa ^a   Minoda, Masaya ^a   Kurosaka, Masahiro ^a   Akisue, Toshihiro ^a  

^a KOBE UNIVERSITY   (Japan)

^b NeoChemir Inc   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; PPARGC1A PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

APOPTOSIS; CELL LINE; CELL PROLIFERATION; CELL TRANSFORMATION; DERMATOFIBROMA; HUMAN; METABOLISM; MITOCHONDRION; MUSCULOSKELETAL SYSTEM; OSTEOSARCOMA; PATHOLOGY; PHYSIOLOGY; SARCOMA; TUMOR CELL LINE;

APOPTOSIS; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; MITOCHONDRIA; MUSCULOSKELETAL SYSTEM; OSTEOSARCOMA; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SARCOMA; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 84901830385     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep03916     Document Type: Article

References (52)

1. LeDoussal, V. et al. Prognostic factors for patients with localized primary malignant fibrous histiocytoma: a multicenter study of 216 patients with multivariate analysis. Cancer. 77, 1823-1830 (1996).
2. Okada, Y. et al. The effect of bevacizumab on tumour growth of malignant fibrous histiocytoma in an animal model. Anticancer. Res. 30, 3391-3395 (2010).
3. Fukase, N. et al. Protein kinase Cdelta in tumorigenesis of human malignant fibrous histiocytoma. Oncol. Rep. 26, 1221-1226 (2011).
4. Onishi, Y. et al. PKD1 negatively regulates cell invasion, migration and proliferation ability of human osteosarcoma. Int. J. Oncol. 40, 1839-1848 (2012).
5. Chan, D. C. Mitochondria: dynamic organelles in disease, aging, and development. Cell. 125, 1241-1252 (2006).
6. Chen, X. J. & Butow, R. A. The organization and inheritance of themitochondrial genome. Nat. Rev. Genet. 6, 815-825 (2005).
7. Weitzel, J. M., Iwen, K. A. & Seitz, H. J. Regulation of mitochondrial biogenesis by thyroid hormone. Exp. Physiol. 88, 121-128 (2003).
8. Hoppeler, H., Vogt, M., Weibel, E. R. & Fluck, M. Response of skeletal muscle mitochondria to hypoxia. Exp. Physiol. 88, 109-119 (2003).
9. Yamada, S. et al. Correlation between copy number of mitochondrial DNA and clinico-pathologic parameters of hepatocellular carcinoma. Eur. J. Surg. Oncol. 32, 303-307 (2006).
10. Yu, M. et al. Reduced mitochondrial DNA copy number is correlated with tumor progression and prognosis in Chinese breast cancer patients. IUBMB. Life. 59, 450-457 (2007).
11. Wu, C. W. et al. Mitochondrial DNA mutations and mitochondrial DNA depletion in gastric cancer. Genes. Chromosomes. Cancer. 44, 19-28 (2005).
12. Lee, H. C. et al. Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma. Mutat. Res. 547, 71-78 (2004).
13. Xing, J. et al. Mitochondrial DNA content: its genetic heritability and association with renal cell carcinoma. J. Natl. Cancer. Inst. 100, 1104-1112 (2008).
14. Tseng, L. M. et al. Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer. Genes. Chromosomes & Cancer. 45, 629-638 (2006).
15. Kim, M. M. et al. Mitochondrial DNA quantity increases with histopathologic grade in premalignant andmalignant head and neck lesions. Clin. Cancer. Res. 10, 8512-8515 (2004).
16. Lin, C. S. et al. The role of mitochondrial DNA alterations in esophageal squamous cell carcinomas. J. Thorac. Cardiovasc. Surg. 139, 189-197 e184 (2010).
17. Wang, Y., Liu, V. W., Xue, W. C., Cheung, A. N. & Ngan, H. Y. Association of decreased mitochondrial DNA content with ovarian cancer progression. Br. J. Cancer. 95, 1087-1091 (2006).
18. Yu, M., Wan, Y. & Zou, Q. Decreased copy number of mitochondrial DNA in Ewing's sarcoma. Clin. Chim. Acta. 411, 679-683 (2010).
19. Lee, H. C. & Wei, Y. H. Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress. Int. J. Biochem. Cell. Biol. 37, 822-834 (2005).
20. Puigserver, P. & Spiegelman, B. M. Peroxisome proliferator-activated receptorgamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr. Rev. 24, 78-90 (2003).
21. Wu, Z. et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell. 98, 115-124 (1999).
22. Ekstrand, M. I. et al. Mitochondrial transcription factor A regulates mtDNA copy number in mammals. Hum. Mol. Genet. 13, 935-944 (2004).
23. Watkins, G., Douglas-Jones, A., Mansel, R. E. & Jiang, W. G. The localisation and reduction of nuclear staining of PPARgammaand PGC-1 in human breast cancer. Oncol. Rep. 12, 483-488 (2004).
24. Feilchenfeldt, J., Brundler, M. A., Soravia, C., Totsch, M. & Meier, C. A. Peroxisome proliferator-activated receptors (PPARs) and associated transcription factors in colon cancer: reduced expression of PPARgammacoactivator 1 (PGC-1). Cancer. Lett. 203, 25-33 (2004).
25. Ba, Y., Zhang, C. N., Zhang, Y. & Zhang, C. Y. Down-regulation of PGC-1alpha expression in human hepatocellular carcinoma. Zhonghua. Zhong. Liu. Za. Zhi. 30, 593-597 (2008).
26. Zhang, Y. et al. PGC-1alpha induces apoptosis in human epithelial ovarian cancer cells through a PPARgamma-dependent pathway. Cell. Res. 17, 363-373 (2007).
27. Sauer, H., Engel, S., Milosevic, N., Sharifpanah, F. & Wartenberg, M. Activation of AMP-kinase by AICAR induces apoptosis of DU-145 prostate cancer cells through generation of reactive oxygen species and activation of c-Jun N-terminal kinase. Int. J. Oncol. 40, 501-508 (2012).
28. Elliott, R. L., Jiang, X. P. & Head, J. F. Mitochondria organelle transplantation: introduction of normal epithelial mitochondria into human cancer cells inhibits proliferation and increases drug sensitivity. Breast. Cancer. Res. Treat. 136, 347-354 (2012).
29. Oe, K. et al. The effect of transcutaneous application of carbon dioxide (CO2) on skeletal muscle. Biochem. Biophys. Res. Commun. 407, 148-152 (2011).
30. Onishi, Y. et al. Transcutaneous application of carbon dioxide (CO2) induces mitochondrial apoptosis in human malignant fibrous histiocytoma in vivo. Plos. One. 7, e49189 (2012).
31. Selvanayagam, P. & Rajaraman, S. Detection of mitochondrial genome depletion by a novel cDNA in renal cell carcinoma. Lab. Invest. 74, 592-599 (1996).
32. Simonnet, H. et al. Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma. Carcinogenesis. 23, 759-768 (2002).
33. Akimoto, T., Sorg, B. S. & Yan, Z. Real-time imaging of peroxisome proliferator activated receptor-gamma coactivator-1alpha promoter activity in skeletal muscles of living mice. Am. J. Physiol. Cell. Physiol. 287, C790-796 (2004).
34. Wang, Y. et al. The increase of mitochondrial DNA content in endometrial adenocarcinoma cells: a quantitative study using laser-captured microdissected tissues. Gynecol. Oncol. 98, 104-110 (2005).
35. Warburg, O. On respiratory impairment in cancer cells. Science. 124, 269-270 (1956).
36. Shadel, G. S. Expression and maintenance of mitochondrial DNA: new insights into human disease pathology. Am. J. Pathol. 172, 1445-1456 (2008).
37. Carew, J. S. & Huang, P. Mitochondrial defects in cancer. Mol. Cancer. 1, 9 (2002).
38. Clayton, D. A. Replication and transcription of vertebrate mitochondrial DNA. Annu. Rev. Cell. Biol. 7, 453-478 (1991).
39. Chandel, N. S. & Schumacker, P. T. Cells depleted of mitochondrial DNA (rho0) yield insight into physiological mechanisms. FEBS. Lett. 454, 173-176 (1999).
40. Higuchi, M., Aggarwal, B. B. & Yeh, E. T. Activation of CPP32-like protease in tumor necrosis factor-induced apoptosis is dependent onmitochondrial function. J. Clin. Invest. 99, 1751-1758 (1997).
41. Ralph, S. J. & Neuzil, J. Mitochondria as targets for cancer therapy. Mol. Nutr. Food. Res. 53, 9-28 (2009).
42. Gogvadze, V., Orrenius, S. & Zhivotovsky, B. Mitochondria in cancer cells: what is so special about them? Trends. Cell. Biol. 18, 165-173 (2008).
43. Kluza, J. et al. Mitochondrial proliferation during apoptosis induced by anticancer agents: effects of doxorubicin and mitoxantrone on cancer and cardiac cells. Oncogene. 23, 7018-7030 (2004).
44. Reipert, S., Berry, J., Hughes, M. F., Hickman, J. A. & Allen, T. D. Changes of mitochondrial mass in the hemopoietic stem cell line FDCP-mix after treatment with etoposide: a correlative study by multiparameter flow cytometry and confocal and electron microscopy. Exp. Cell. Res. 221, 281-288 (1995).
45. Eliseev, R. A., Gunter, K. K. & Gunter, T. E. Bcl-2 prevents abnormal mitochondrial proliferation during etoposide-induced apoptosis. Exp. Cell. Res. 289, 275-281 (2003).
46. Mancini, M. et al. Mitochondrial proliferation and paradoxical membrane depolarization during terminal differentiation and apoptosis in a human colon carcinoma cell line. J. Cell. Biol. 138, 449-469 (1997).
47. Skildum, A., Dornfeld, K. & Wallace, K. Mitochondrial amplification selectively increases doxorubicin sensitivity in breast cancer cells with acquired antiestrogen resistance. Breast. Cancer. Res. Treat. 129, 785-797 (2011).
48. Xu, R.H. et al. Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer. Res. 65, 613-621 (2005).
49. Hitora, T. et al. Establishment and characterization of a KIT-positive and stem cell factor-producing cell line, KTHOS, derived from human osteosarcoma. Pathol. Int. 55, 41-7 (2005).
50. Nakatani, T. et al. Establishment and characterization of cell line TNMY1 derived from human malignant fibrous histiocytoma. Pathol. Int. 51, 595-602 (2001).
51. Kiyozuka, Y. et al. Novel cell lines established from a human myxoid malignant fibrous histiocytoma arising in the uterus. Cancer. Genet. Cytogenet. 127, 7-15 (2001).
52. Takayama, K. et al. SIRT1 regulation of apoptosis of human chondrocytes. Arthritis. Rheum. 60, 2731-2740 (2009).